Live Breaking News & Updates on Zentalis Pharmaceuticals Company Profile

Stay updated with breaking news from Zentalis pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Downgraded by Wedbush to Neutral

Wedbush lowered shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from an outperform rating to a neutral rating in a research note released on Wednesday, MarketBeat reports. They currently have $12.00 price objective on the stock, down from their previous price objective of $38.00. Wedbush also issued estimates for Zentalis Pharmaceuticals’ Q4 2023 earnings at […] ....

Melissab-epperly , Jan-skvarka , Stifel-nicolaus , Securities-exchange-commission , Analyst-recommendations-for-zentalis-pharmaceuticals , Zentalis-pharmaceuticals-trading-down , Zentalis-pharmaceuticals , News-ratings-for-zentalis-pharmaceuticals-daily , Scharf-investments , Zentalis-pharmaceuticals-inc , Institutional-trading-of-zentalis-pharmaceuticals , Zentalis-pharmaceuticals-company-profile

HC Wainwright Trims Zentalis Pharmaceuticals (NASDAQ:ZNTL) Target Price to $46.00

Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its target price reduced by HC Wainwright from $55.00 to $46.00 in a report published on Tuesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Zentalis Pharmaceuticals’ Q4 2023 earnings at ($0.83) EPS, FY2023 earnings at ($4.44) EPS, […] ....

Melissab-epperly , Carrie-brownstein , Us-bancorp , Metlife-investment-management , News-ratings-for-zentalis-pharmaceuticals-daily , Jpmorgan-chase-co , Zentalis-pharmaceuticals-company-profile , Analyst-recommendations-for-zentalis-pharmaceuticals , Institutional-investors-weigh-in-on-zentalis-pharmaceuticals , Zentalis-pharmaceuticals-trading-down , Zentalis-pharmaceuticals-inc , Dimensional-fund-advisors

Zentalis Pharmaceuticals (NASDAQ:ZNTL) PT Lowered to $38.00 at Morgan Stanley

Zentalis Pharmaceuticals (NASDAQ:ZNTL) PT Lowered to $38.00 at Morgan Stanley
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Arizona , United-states , Florida , Jan-skvarka , Melissab-epperly , Charles-schwab-investment-management-inc , Analyst-recommendations-for-zentalis-pharmaceuticals , Institutional-trading-of-zentalis-pharmaceuticals , Zentalis-pharmaceuticals , Board-of-administration-florida-retirement-system , Morgan-stanley , First-advisors-inc

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Stock Price Down 3.2%

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) traded down 3.2% on Monday . The stock traded as low as $18.21 and last traded at $18.34. 146,579 shares were traded during trading, a decline of 79% from the average session volume of 706,325 shares. The stock had previously closed at $18.94. Wall Street […] ....

Melissab-epperly , Jan-skvarka , Matrix-capital-management-company , Zentalis-pharmaceuticals-stock-performance , Institutional-trading-of-zentalis-pharmaceuticals , Nasdaq , Blackrock-inc , News-ratings-for-zentalis-pharmaceuticals-daily , Zentalis-pharmaceuticals-company-profile , Zentalis-pharmaceuticals , Wells-fargo-company

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Director Jan Skvarka Sells 5,000 Shares

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) Director Jan Skvarka sold 5,000 shares of the stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $25.05, for a total transaction of $125,250.00. Following the transaction, the director now directly owns 47,970 shares of the company’s […] ....

Stifel-nicolaus , Jan-skvarka , Pricet-rowe-associates-inc , Wells-fargo-company , Zentalis-pharmaceuticals , Zentalis-pharmaceuticals-stock-performance , Zentalis-pharmaceuticals-company-profile , Eventide-asset-management , Matrix-capital-management-company , News-ratings-for-zentalis-pharmaceuticals-daily , Zentalis-pharmaceuticals-inc